CD63(+) Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22

Tamoxifen remains the most effective treatment for estrogen receptor α (ERα)‐positive breast cancer. However, many patients still develop resistance to tamoxifen in association with metastatic recurrence, which presents a tremendous clinical challenge. To better understand tamoxifen resistance from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Adv Sci (Weinh)
Main Authors: Gao, Yuan, Li, Xiaoju, Zeng, Cheng, Liu, Chenlin, Hao, Qiang, Li, Weina, Zhang, Kuo, Zhang, Wangqian, Wang, Shuning, Zhao, Huadong, Fan, Dong, Li, Meng, Zhang, Yingqi, Zhang, Wei, Zhang, Cun
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Full Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7610308/
https://ncbi.nlm.nih.gov/pubmed/33173749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202002518
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados